BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16759236)

  • 1. What we call them: the nomenclature of head and neck paragangliomas.
    Martin TP
    Clin Otolaryngol; 2006 Jun; 31(3):185-6. PubMed ID: 16759236
    [No Abstract]   [Full Text] [Related]  

  • 2. Which paragangliomas of the head and neck have a higher rate of malignancy?
    Rinaldo A; Myssiorek D; Devaney KO; Ferlito A
    Oral Oncol; 2004 May; 40(5):458-60. PubMed ID: 15006616
    [No Abstract]   [Full Text] [Related]  

  • 3. Paragangliomas: classification, pathology, and differential diagnosis.
    Wasserman PG; Savargaonkar P
    Otolaryngol Clin North Am; 2001 Oct; 34(5):845-62, v-vi. PubMed ID: 11557443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basic fibroblast growth factor and fibroblastic growth factor receptor-1 may contribute to head and neck paraganglioma development by an autocrine or paracrine mechanism.
    Douwes Dekker PB; Kuipers-Dijkshoorn NJ; Baelde HJ; van der Mey AG; Hogendoorn PC; Cornelisse CJ
    Hum Pathol; 2007 Jan; 38(1):79-85. PubMed ID: 16949906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Classification of head and neck paragangliomas].
    Pérez Plasencia D; Gutiérrez Fonseca R; Ramos Macías A
    Acta Otorrinolaringol Esp; 2009 Feb; 60 Suppl 1():29-33. PubMed ID: 19245773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The new classification of Head and Neck Tumours (WHO)--any changes?
    Reichart PA; Philipsen HP; Sciubba JJ
    Oral Oncol; 2006 Sep; 42(8):757-8. PubMed ID: 16679047
    [No Abstract]   [Full Text] [Related]  

  • 7. Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Paragangliomas.
    Williams MD; Tischler AS
    Head Neck Pathol; 2017 Mar; 11(1):88-95. PubMed ID: 28247224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Paragangliomas in the head-/neck region. I: Classification and diagnosis].
    Schipper J; Boedeker CC; Maier W; Neumann HP
    HNO; 2004 Jun; 52(6):569-74; quiz 575. PubMed ID: 15241514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunohistologic findings in paragangliomas in the area of the head and neck].
    Milewski C; Dienes HP; Collo D
    Laryngol Rhinol Otol (Stuttg); 1988 Aug; 67(8):385-8. PubMed ID: 3062287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. World Health Organization classification of tumours: pathology and genetics of head and neck tumours.
    Thompson L
    Ear Nose Throat J; 2006 Feb; 85(2):74. PubMed ID: 16579185
    [No Abstract]   [Full Text] [Related]  

  • 11. [Paragangliomas of neck and temporal bone].
    Ojalehto M; Tikkakoski T; Siniluoto T
    Duodecim; 2001; 117(3):261-7. PubMed ID: 12092394
    [No Abstract]   [Full Text] [Related]  

  • 12. High prevalence of SDHB mutations in head and neck paraganglioma in Belgium.
    Persu A; Hamoir M; Grégoire V; Garin P; Duvivier E; Reychler H; Chantrain G; Mortier G; Mourad M; Maiter D; Vikkula M
    J Hypertens; 2008 Jul; 26(7):1395-401. PubMed ID: 18551016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Head and neck paragangliomas. Embryological origin and anatomical characteristics: topographic distribution and vascularization pattern].
    Carretero González J; Blanco Pérez P; Vázquez Osorio MT; Benito González F; Sañudo Tejedo JR
    Acta Otorrinolaringol Esp; 2009 Feb; 60 Suppl 1():9-17. PubMed ID: 19245770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Histological characteristics of head and neck paragangliomas].
    Antúnez Plaza P; Santos-Briz Terrón A; Sáncho de Salas M; Flores Corral T
    Acta Otorrinolaringol Esp; 2009 Feb; 60 Suppl 1():18-23. PubMed ID: 19245771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Head and neck paraganglioma--neoplasm of nervous origin].
    Dorobisz AT; Zaleska P
    Pol Merkur Lekarski; 2004 Sep; 17(99):292-6. PubMed ID: 15628063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Head and neck paragangliomas: physiology and biochemistry.
    McCaffrey TV; Myssiorek D; Marrinan M
    Otolaryngol Clin North Am; 2001 Oct; 34(5):837-44, v. PubMed ID: 11557442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paragangliomas arise through an autonomous vasculo-angio-neurogenic program inhibited by imatinib.
    Verginelli F; Perconti S; Vespa S; Schiavi F; Prasad SC; Lanuti P; Cama A; Tramontana L; Esposito DL; Guarnieri S; Sheu A; Pantalone MR; Florio R; Morgano A; Rossi C; Bologna G; Marchisio M; D'Argenio A; Taschin E; Visone R; Opocher G; Veronese A; Paties CT; Rajasekhar VK; Söderberg-Nauclér C; Sanna M; Lotti LV; Mariani-Costantini R
    Acta Neuropathol; 2018 May; 135(5):779-798. PubMed ID: 29305721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paraganglioma of the head and neck: long-term local control with radiotherapy.
    Chino JP; Sampson JH; Tucci DL; Brizel DM; Kirkpatrick JP
    Am J Clin Oncol; 2009 Jun; 32(3):304-7. PubMed ID: 19433962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sympathetic paraganglioma presenting with Horner's syndrome in a child.
    Kansal A; Lahiri A; Nishikawa H
    J Plast Reconstr Aesthet Surg; 2006; 59(7):772-4. PubMed ID: 16782577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and molecular progress in hereditary paraganglioma.
    Baysal BE
    J Med Genet; 2008 Nov; 45(11):689-94. PubMed ID: 18978332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.